Trial Profile
The Applicability of the OAB Assessment Tool for Evaluation of Treatment Efficacy of Overactive Bladder.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 12 Mar 2010 New trial record